John E. (Jack) Bailey Jr., President and CEO at G1 Therapeutics, Inc. (GTHX), sold 69,645 shares at $5.85 ($406K) on 2023-01-03, disclosed to the SEC on 2023-01-05.
Open-market sale of $406k GTHX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.85 | 32,019 | $187K | 46.1% |
| 2 | $5.85 | 32,019 | $187K | 46.1% |
| 3 | $5.58 | 5,607 | $31K | 7.7% |
| Total | $5.83 avg | 69,645 | $406K | 100% |
| Filing → |
| GTHX | SELL | 2024-01-08 | $36K | — | Filing → |
| GTHX | SELL | 2024-01-02 | $216K | — | Filing → |
| GTHX | SELL | 2023-07-07 | $7K | — | Filing → |